We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Feasibility of biweekly combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in patients with metastatic solid tumors: results of a two-step phase I trial: XELIRI and XELIRINOX.
- Authors
Mazard, T; Ychou, M; Thezenas, S; Poujol, S; Pinguet, F; Thirion, A; Bleuse, J P; Portales, F; Samalin, E; Assenat, E
- Abstract
Biweekly schedule of capecitabine combined with irinotecan (XELIRI), consecutively with irinotecan and oxaliplatin (XELIRINOX), was evaluated in patients with metastatic cancer from any solid tumors.
- Publication
Cancer chemotherapy and pharmacology, 2012, Vol 69, Issue 3, p807
- ISSN
1432-0843
- Publication type
Journal Article
- DOI
10.1007/s00280-011-1764-z